LLMpediaThe first transparent, open encyclopedia generated by LLMs

Jim Manzi

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Lotus 1-2-3 Hop 4
Expansion Funnel Raw 61 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted61
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Jim Manzi
NameJim Manzi
Birth date1951
OccupationEntrepreneur, writer, consultant
EducationHarvard College, Stanford University
Known forFounder of Applied Predictive Technologies

Jim Manzi is an American entrepreneur, technology executive, and author known for founding a business analytics firm and for commentary on public policy, statistics, and health. He has been involved in technology startups, venture capital, and policy debates involving healthcare, climate change, and pandemic response. Manzi’s career bridges technology management at McKinsey & Company, applied data analytics, and contributions to public discourse via essays and books.

Early life and education

Manzi was born in 1951 and grew up in the United States. He attended Harvard College where he studied philosophy and history before earning a graduate degree at Stanford University. During his formative years he had exposure to management consulting and technology sectors through internships and early work with firms including McKinsey & Company, which influenced his later career in analytics and entrepreneurship.

Business career

Manzi founded Applied Predictive Technologies (APT), a firm providing causal inference and A/B testing services for businesses, and served as its chief executive. Under his leadership APT worked with clients across industries including Walmart, Procter & Gamble, AT&T, Verizon Communications, and Bank of America to measure the impact of marketing and operational changes. The company used experiments and observational methods drawing on ideas from Donald Rubin, Jerome Cornfield, and Judea Pearl to estimate treatment effects. APT attracted investment from firms such as Battery Ventures and engaged with corporate customers including Target Corporation and The Home Depot. Manzi later served as an investor and board member in various technology and healthcare ventures, interacting with organizations like Google, Microsoft, IBM, Oracle Corporation, and Palantir Technologies.

Before founding APT, Manzi worked at McKinsey & Company and held management roles that connected him with leaders in Silicon Valley and the broader technology industry. His entrepreneurial activities included advising venture capital firms and startups, and participating in policy-relevant technology discussions with institutions such as Brookings Institution, American Enterprise Institute, Hoover Institution, and Cato Institute.

Writing and public commentary

Manzi authored books and numerous essays addressing measurement, policy, and scientific inference. His book topics intersect with work by scholars and writers including Daniel Kahneman, Amartya Sen, Angus Deaton, Philip Tetlock, and Nassim Nicholas Taleb. He has published in venues associated with National Review, The Wall Street Journal, The New York Times, and policy outlets at Hoover Institution and American Enterprise Institute. Manzi has been featured or cited alongside commentators such as Fareed Zakaria, Thomas Sowell, David Brooks, Paul Krugman, and Steven Pinker in debates on public policy and science. He has participated in panel discussions and podcasts with academics from Harvard University, Stanford University, Massachusetts Institute of Technology, and University of Chicago.

Views on public policy and science

Manzi advocates for evidence-based policy using randomized experiments, quasi-experimental designs, and rigorous statistical analysis inspired by work from Jerome Cornfield, Donald Rubin, and Judea Pearl. He has argued about pandemic preparedness and response in the context of debates involving Centers for Disease Control and Prevention, World Health Organization, and public-health leaders such as Anthony Fauci and Tom Frieden. In climate policy discussions he has engaged with research from Intergovernmental Panel on Climate Change, economists like William Nordhaus and Nordhaus-adjacent cost–benefit analysis, and critics including Bjorn Lomborg and Richard Lindzen. On technology and regulation he has weighed trade-offs discussed by scholars at Brookings Institution, Cato Institute, and Hoover Institution, emphasizing measurement, incentives, and the limits of forecasting highlighted by Philip Tetlock.

Manzi’s positions have been characterized as supportive of market-oriented solutions and skeptical of policy actions lacking clear experimental or empirical validation, aligning him with commentators such as Tyler Cowen and Iain Murray. He has critiqued what he views as overreliance on models without empirical testing, referencing methodological debates involving Thomas S. Kuhn, Karl Popper, and Paul Meehl.

Personal life and philanthropy

Manzi has engaged in philanthropic activities and supported education and research initiatives. He has been involved with nonprofit organizations and think tanks including Hoover Institution, American Enterprise Institute, and regional educational programs. Manzi has served on advisory boards and contributed to funding research at institutions such as Harvard University, Stanford University, and local community foundations. He resides in the United States and has participated in civic and charitable efforts connected to health, education, and scientific research.

Category:American businesspeople Category:Technology executives